Reduced miR-202 levels enhanced oral cancer development via targeting Sp1.

Zhao J, Ding D, Zhao G

DOI: 10.3892/etm.2019.7603
Published: 2019 Jul
Container: Experimental and therapeutic medicine
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3892/etm.2019.7603,
  title = {Reduced miR-202 levels enhanced oral cancer development via targeting Sp1.},
  author = {Zhao J and Ding D and Zhao G},
  year = {2019},
  journal = {Experimental and therapeutic medicine},
  doi = {10.3892/etm.2019.7603},
  url = {https://doi.org/10.3892/etm.2019.7603}
}

RIS

TY  - JOUR
TI  - Reduced miR-202 levels enhanced oral cancer development via targeting Sp1.
AU  - Zhao J
AU  - Ding D
AU  - Zhao G
PY  - 2019
JO  - Experimental and therapeutic medicine
DO  - 10.3892/etm.2019.7603
UR  - https://doi.org/10.3892/etm.2019.7603
ER  -

APA

J, Z., D, D., & G, Z. (2019). Reduced miR-202 levels enhanced oral cancer development via targeting Sp1.. Experimental and therapeutic medicine. https://doi.org/10.3892/etm.2019.7603

Source records

pubmed · retrieved 2026-09-24T19:27:22.440Z